Stockscreener 앱 받기
11.84
0.92%
-0.11
시간 외 거래:
11.84
전일 마감가:
$11.95
열려 있는:
$11.82
하루 거래량:
264.85K
Relative Volume:
1.10
시가총액:
$73.92M
수익:
-
순이익/손실:
$-14.56M
주가수익비율:
-0.7039
EPS:
-16.82
순현금흐름:
$-12.46M
1주 성능:
+0.77%
1개월 성능:
-4.21%
6개월 성능:
+97.50%
1년 성능:
+90.05%
1일 변동 폭
$11.50
$12.19
1주일 범위
$11.11
$12.40
52주 변동 폭
$4.63
$18.38
Tenax Therapeutics Inc Stock (TENX) Company Profile
명칭
Tenax Therapeutics Inc
전화
919-855-2100
주소
101 GLEN LENNOX DRIVE, CHAPEL HILL, NC
Compare TENX vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TENX
Tenax Therapeutics Inc
|
11.84 | 74.61M | 0 | -14.56M | -12.46M | -16.82 |
|
VRTX
Vertex Pharmaceuticals Inc
|
460.82 | 121.40B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
764.93 | 83.25B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
728.14 | 46.39B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
320.51 | 43.41B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
292.94 | 33.09B | 5.36B | 287.73M | 924.18M | 2.5229 |
Tenax Therapeutics Inc Stock (TENX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-09-08 | 개시 | Piper Sandler | Overweight |
| 2024-10-24 | 개시 | Leerink Partners | Outperform |
| 2024-10-14 | 개시 | Guggenheim | Buy |
| 2024-09-30 | 개시 | William Blair | Outperform |
| 2017-05-18 | 업그레이드 | Ladenburg Thalmann | Neutral → Buy |
| 2014-12-16 | 개시 | MLV & Co | Buy |
| 2014-11-18 | 개시 | WallachBeth | Buy |
모두보기
Tenax Therapeutics Inc 주식(TENX)의 최신 뉴스
Tenax Therapeutics (NASDAQ:TENX) Shares Cross Above 200 Day Moving AverageHere's What Happened - MarketBeat
Tenax Therapeutics to Participate in the 2026 Leerink Partners Global Healthcare Conference - GlobeNewswire
How Tenax Therapeutics Inc. (TENX) Affects Rotational Strategy Timing - Stock Traders Daily
Tenax Therapeutics: Some Future Potential (NASDAQ:TENX) - Seeking Alpha
TENX Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Tenax Therapeutics (NASDAQ:TENX) Stock Price Passes Above Two Hundred Day Moving AverageWhat's Next? - MarketBeat
RTW INVESTMENTS, LP Acquires Additional Shares in Tenax Therapeu - GuruFocus
(TENX) and the Role of Price-Sensitive Allocations - Stock Traders Daily
Market Wrap: What are Tenax Therapeutics Incs recent SEC filings showing - baoquankhu1.vn
Point72 reports 6.8% Tenax (TENX) stake via 423,415 shares - Stock Titan
Is Tenax Therapeutics Inc. stock a good pick for beginnersWeekly Market Report & Consistent Profit Alerts - mfd.ru
Tenax Therapeutics Shares Phase III Levosimendan Progress, H2 Data Timeline at Guggenheim Conference - MarketBeat
Is Tenax Therapeutics Inc. stock positioned for long term growthShort Setup & AI Enhanced Trading Alerts - mfd.ru
Is Tenax Therapeutics Inc. stock a safe haven asset2025 Sector Review & Low Drawdown Trading Techniques - mfd.ru
TENX Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Will Tenax Therapeutics Inc. benefit from rising consumer demand2025 Price Action Summary & Real-Time Volume Analysis - mfd.ru
Tenax Therapeutics (NASDAQ:TENX) Stock Passes Above 200 Day Moving AverageWhat's Next? - MarketBeat
Will Tenax Therapeutics Inc. outperform tech stocksJuly 2025 Summary & Risk Adjusted Buy and Sell Alerts - mfd.ru
[SCHEDULE 13G] TENAX THERAPEUTICS, INC. Passive Investment Disclosure (>5%) - Stock Titan
Is Tenax Therapeutics Inc. stock a top performer YTDPortfolio Profit Report & Precise Entry and Exit Recommendations - mfd.ru
Responsive Playbooks and the TENX Inflection - Stock Traders Daily
Bear Alert: What hedge funds are buying Tenax Therapeutics IncWeekly Earnings Recap & Consistent Profit Focused Trading Strategies - baoquankhu1.vn
Tenax Therapeutics (NASDAQ:TENX) Shares Pass Above 200 Day Moving AverageShould You Sell? - MarketBeat
Tenax Therapeutics (NASDAQ:TENX) Shares Pass Above 200 Day Moving Average – Should You Sell? - Defense World
Tenax Therapeutics to Participate in the Guggenheim Emerging Outlook Biotech Summit 2026 - Investing News Network
Risk Report: Is Harris Oakmark Etf Trust stock a hidden gemQuarterly Trade Summary & Weekly Breakout Opportunity Watchlist - baoquankhu1.vn
Fundamentals Check: What is the next catalyst for Tenax Therapeutics IncPortfolio Return Summary & AI Forecasted Stock Moves - baoquankhu1.vn
Is Tenax Therapeutics Inc. still a buy after recent gains2025 Market Overview & Safe Capital Growth Tips - mfd.ru
Understanding the Setup: (TENX) and Scalable Risk - Stock Traders Daily
Tenax Therapeutics (NASDAQ:TENX) Shares Pass Above 200-Day Moving AverageHere's Why - MarketBeat
Aug Macro: Is Tenax Therapeutics Inc forming a double bottomWall Street Watch & Proven Capital Preservation Tips - baoquankhu1.vn
Aug Movers: Will CPSP face regulatory challengesTrade Risk Assessment & Risk Managed Investment Entry Signals - baoquankhu1.vn
Financial Survey: Biorestorative Therapies (NASDAQ:BRTX) vs. Tenax Therapeutics (NASDAQ:TENX) - Defense World
The Technical Signals Behind (TENX) That Institutions Follow - Stock Traders Daily
Investment Review: Can Tenax Therapeutics Inc stock outperform in 2025 bull marketPortfolio Growth Summary & Low Drawdown Investment Strategies - Bộ Nội Vụ
Published on: 2026-01-14 00:08:43 - Bộ Nội Vụ
Tenax Therapeutics (NASDAQ:TENX) Share Price Passes Above Two Hundred Day Moving AverageHere's What Happened - MarketBeat
Tenax Therapeutics Updates Chief Medical Officer Agreement - The Globe and Mail
Guggenheim doubles Tenax (TENX) PT, names stock top pick - MSN
Tenax Therapeutics Stock: A Speculative Buy (NASDAQ:TENX) - Seeking Alpha
How Tenax Therapeutics Inc. stock reacts to oil prices2025 Trading Recap & Real-Time Stock Entry Alerts - Улправда
Is Tenax Therapeutics Inc. stock cheap at current valuationJuly 2025 Selloffs & Daily Profit Maximizing Tips - Улправда
Why Tenax Therapeutics Inc. stock is considered a top pickJuly 2025 Big Picture & AI Forecasted Stock Moves - ulpravda.ru
Guggenheim Doubles Tenax (TENX) PT, Names Stock Top Pick - Finviz
Will Tenax Therapeutics Inc. stock see insider buyingRisk Management & Low Drawdown Trading Techniques - Улправда
Earnings Beat: Is Tenax Therapeutics Inc. stock overvalued by current metrics2025 Support & Resistance & Risk Managed Investment Signals - Улправда
Is Tenax Therapeutics Inc. stock near bottom after declineWeekly Trend Report & Low Volatility Stock Suggestions - Улправда
What is the fair value of Tenax Therapeutics Inc. stock nowEarnings Performance Report & Real-Time Buy Signal Notifications - Улправда
Precision Trading with Tenax Therapeutics Inc. (TENX) Risk Zones - Stock Traders Daily
Tenax Therapeutics: How Lower Variance In Phase 3 Has "Loaded The Dice" For An Asymmetric Repricing - Seeking Alpha
12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga
Tenax Therapeutics Inc (TENX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Tenax Therapeutics Inc 주식 (TENX) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Rich Stuart | Chief Medical Officer |
Dec 08 '25 |
Buy |
10.10 |
2,500 |
25,250 |
5,000 |
| Rich Stuart | Chief Medical Officer |
Dec 04 '25 |
Buy |
9.20 |
2,500 |
22,998 |
2,500 |
| Rich Stuart | Chief Medical Officer |
Dec 03 '25 |
Buy |
9.08 |
1,500 |
13,618 |
2,766 |
| Rich Stuart | Chief Medical Officer |
Dec 02 '25 |
Buy |
9.01 |
1,000 |
9,006 |
1,266 |
| Giordano Christopher Thomas | CEO |
Nov 18 '25 |
Buy |
7.75 |
1,612 |
12,500 |
1,612 |
| Giordano Christopher Thomas | CEO |
Nov 20 '25 |
Buy |
7.59 |
538 |
4,083 |
2,605 |
| Giordano Christopher Thomas | CEO |
Nov 19 '25 |
Buy |
7.51 |
455 |
3,417 |
2,067 |
| MCGAULEY THOMAS | Interim CFO |
Nov 17 '25 |
Buy |
7.25 |
6,000 |
43,490 |
5,000 |
| MCGAULEY THOMAS | Interim CFO |
Nov 17 '25 |
Buy |
7.34 |
2,000 |
14,674 |
2,000 |
| Almenoff June Sherie | Director |
Nov 18 '25 |
Buy |
7.52 |
1,900 |
14,280 |
1,993 |
3.69%
0.71%
자본화:
|
볼륨(24시간):